The question of feedback at the somadendritic region and antidepressant drug action

Brain Research Bulletin

Volumn 52, Issue 6, 2000, Pages 467-473

  Kalsner, Stanley ^a  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

5 HT uptake inhibitors; Antidepressant drug action; Negative feedback theory; Serotonergic mechanisms; Serotonergic neurons

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; PINDOLOL; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

DENDRITE; DORSAL RAPHE NUCLEUS; NEGATIVE FEEDBACK; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SEROTONINERGIC NERVE CELL;

ANIMALS; ANTIDEPRESSIVE AGENTS; DENDRITES; FEEDBACK; HUMANS; RECEPTORS, SEROTONIN; SYNAPSES;

EID: 0033842953     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(00)00289-6     Document Type: Review

References (72)

1. Adell, A.; Artigas, F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe and frontal cortex. Naunyn-Schmiedebergs Arch. Pharmacol. 343: 237-244; 1991.
2. Adell, A.; Artigas, F. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. Br. J. Pharmacol. 125:1361-1367; 1998.
3. Aghajanian, G. K.; Haigler, H. J. Studies on the physiological activity of 5-HT neurons. In: Pharmacology and the future of man, Proceedings of the 5th International Congress of Pharmacology, San Francisco, 1972, vol. 4. Basel: S. Karger; 1973:269-285.
4. 1A antagonists. Trends Neurosci. 19:378-383; 1996.
5. Baldesssarini, R. J. Drugs and the treatment of psychiatric disorders. In: Gilman, A. G.; Rail, T. W.; Neis, A. S.; Taylor, P., eds. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press; 1990:383-435.
6. Baraban, J. M.; Aghajanian, G. K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363; 1980.
7. Becquet, D.; Faudon, M.; Hery, F. The role of serotonin release and autoreceptors in the dorsalis raphe nucleus in the control of serotonin release in the cat caudate nucleus. Neuroscience 39:639-647; 1990.
8. Bel, N.; Artigas, F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study. Fur. J. Pharmacol. 229:101-103; 1992.
9. Benmansour, S.; Cecchi, M.; Morilak, D. A.; Gerhardt, G. A.; Javors, M. A.; Gould, G. G.; Frazer, A. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J. Neurosci. 19:10494-10501; 1999.
10. Blier, P.; de Montigny, C. Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: Single-cell recording studies. J. Clin. Psychopharmacol. 10:13S-20S; 1990.
11. Blier, P.; de Montigny, C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:220-226; 1994.
12. Blier, P.; de Montigny, C.; Chaput, Y. Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J. Clin. Psychopharmacol. 7:24S-35S; 1987.
13. Bonvento, G.; Scatton, B.; Claustre, Y.; Rouquier, L. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci. Lett. 137:101-104; 1992.
14. Bosker, F. J.; Klompmakers, A. A.; Westenberg, H. G. M. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitve to tetrodotoxin. J. Neurochem. 63:2165-2171; 1994.
15. Bosker, F. J.; Klompmakers, A. A.; Westenberg, H. G. M. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34:501-508; 1995.
16. Carboni, E.; Di Chiara, G. Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32:637-645; 1989.
17. Chaput, Y.; de Montigny, C.; Blier, P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 333:342-348; 1986.
18. 1A agonists. Synapse 14:297-304; 1993.
19. Craven, R.; Grahame-Smith, D.; Newberry, N. Way-100635 and GR127935: Effects on 5-hydroxytryptamine-containing neurones. Eur. J. Pharmacol. 271:R1-R3; 1994.
20. Cunningham, K. A.; Lakoski, J. M. The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies. Neuropsychopharmacology 3:41-50; 1990.
21. 1A control of dorsal raphe cell firing and 5-HT release. Neuroreport 9:2535-2538; 1998.
22. Daws, L.-C.; Toney, G. M.; Gerhardt, G. A.; Frazer, A. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: Contribution of serotonin and norepinephrine transporters. J. Pharmacol. Exp. Ther. 286:967-976; 1998.
23. Di Mascio, M.; Di Giovanni, G.; Di Matteo, V.; Prisco, S.; Esposito, E. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area. Brain Res. Bull. 46:547-554; 1998.
24. Fuller, R. W. Mininreview uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55:163-167; 1994.
25. 1aautoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 10:16-27; 1996.
26. 1A receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115:1064-1070; 1995.
27. 1A autoreceptors and noradrenergic mechanisms. Psychopharmacology 130:261-268; 1997.
28. Gulyás, A. I.; Acsády, L.; Freund, T. F. Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus. Neurochem. Int. 34:359-372; 1999.
29. Gundlah, C.; Hjorth, S.; Auerbach, S. B. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: This effect persists after repeated citalopram treatment. Neuropharmacology 36:475-482; 1997.
30. Hajós, M.; Gartside, S. E.; Sharp, T. Inhibition of median and dorsal raphe neurons following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn-Schmiedebergs Arch. Pharmacol. 351:624-629; 1995.
31. Helton, D. R.; Colbert, W. E. Alterations of in -vitro 5-HT receptor pharmacology as a function of multiple treatment with 5-hydroxytryptamine or 8-hydroxy-2-(di-N-propylamino) tetralin in rat isolated aorta, uterus and fundus, and guinea-pig isolated trachea. J. Pharm. Pharmacol. 46:902-905; 1994.
32. Hery, F.; Faudon, M.; Ternaux, J.-P. In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat. Brain Res. Bull. 8:123-129; 1982.
33. 1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav. Brain Res. 73:281-283; 1996.
34. 1A (Auto) receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology 36:461-465; 1997.
35. Huffman, B. B.; Lefkowitz, R. J. Catecholamines and sympathomimetic drugs. In: Gilman, A. G.; Rail, T. W.; Nies, A. S.; Taylor, P., eds. Goodman and oilman's the pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press; 1990:187-220.
36. Hutson, P. H.; Sarna, G. S.; O'Connell, M. T.; Curzon, G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci. Lett. 100:276-280; 1989.
37. Invernizzi, R.; Bramante, M.; Samanin, R. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res. 696:62-66; 1995.
38. Jacobs, B. L.; Fornal, C. A. V. activity of brain serotonergic neurons in the behaving animal. Pharmacol. Rev. 43:563-578; 1991.
39. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J. Pharmacol. Exp. Ther. 272:920-929; 1995.
40. Jordan, S.; Kramer, G. L.; Zukas, P. K.; Moeller, M.; Petty, F. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18:294-297; 1994.
41. Kalsner, S. Termination of effector responses to agonists: An analysis of agonist disposition mechanisms. Can. J. Physiol. Pharmacol. 55: 315-331; 1977.
42. Kalsner, S. Termination of agonist action on autonomic receptors. In: Kalsner, S., ed. Trends in autonomie pharmacology, vol. 1. Baltimore/ Munich: Urban and Schwarzenberg; 1979:265-287.
43. Kalsner, S. Sensitization of effector responses by modification of agonist disposition mechanisms. Can. J. Physiol. Pharmacol. 54:177-187; 1976.
44. Kalsner, S.; Westfall, T. C., eds. Presynaptic of receptors and the question of autoregulation of neurotransmitter release, vol. 604. New York: Annals New York Academy of Science; 1990.
45. 1A autoreceptors of the dorsal and median raphe nuclei. Synapse 25:107-116; 1997.
46. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedebergs Arch. Pharmacol. 352:141-148; 1995.
47. 1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine. Chin. J. Physiol. 42:53-59; 1999.
48. Malagié, I.; Trillat, A. C.; Jacquot, C.; Gardier, A. M. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: An in vivo microdialysis study. Eur. J. Pharmacol. 286:213-217; 1995.
49. 1A receptor antagonists on dorsal raphe cell firing. J. Pharmacol. Exp. Ther. 288:820-826; 1999.
50. Matos, F. F.; Urban, C.; Yocca, F. D. Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: Raphé control of somatodendritic and terminal 5-HT release. J. Neural. Transm. 103:173-190; 1996.
51. Maudhuit, C.; Hamon, M.; Adrien, J. Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport 6:681-684; 1995.
52. 1A agonists. Mol. Pharmacol. 37:231-237; 1990.
53. Moret, C.; Briley, M. Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur. J. Pharmacol. 295:189-197; 1996.
54. Nicholson, C.; Rice, M. E. Diffusion of ions and transmitters in the brain cell microenvironment. In: Fuse, K.; Agnati, I. F., eds. Volume transmission in the brain: Novel mechanism for neural transmission. New York: Raven Press; 1991:279-294.
55. O'Connor, J. J.; Kruk, Z. L. Fast cyclic voltammetry can be used to measure stimulated endogenous 5-hydroxytryptamine release in untreated rat brain slices. J. Neurosci. Meth. 38:25-33; 1991.
56. Perry, K. W.; Fuller, R. W. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan. J. Pharm. Pharmacol. 45:759-761; 1993.
57. Quineaux, N.; Scuvée-Moreau, J.; Dresse, A. Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants: Correlation with reduction of spontaneous firing rate of central monoaminergic neurones. Naunyn-Schmiedebergs Arch. Pharmacol. 319:66-70; 1982.
58. Rigdon, G. C.; Wang, C. M. Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphe neurons in vitro. Drug Dev. Res. 22:135-140; 1991.
59. Rutter, J. J.; Auerbach, S. B. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265: 1319-1324; 1993.
60. Rutter, J. J.; Gundlah, C.; Auerbach, S. B. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20:225-233; 1995.
61. 1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat. Eur. J. Pharmacol. 249:341-351; 1993.
62. Sharp, T.; Bramwell, S. R.; Clark, D.; Grahame-Smith, D. G. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: Changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 53:234-240; 1989.
63. Sheard, M. H.; Zolovick, A.; Aghjanian, G. K. Raphe neurons: Effect of tricyclic antidepressant drugs. Brain Res. 43:690-694; 1972.
64. 1A receptor agonist, buspirone, after prolonged chronic administration. Eur. J. Pharmacol. 239:69-73; 1993.
65. 1A receptor ligand. Eur. J. Pharmacol. 201:163-169; 1991.
66. 1A and 5-HT1B agonists. Synapse 1:3-9; 1987.
67. Trulson, M. E.; Crisp, T. Do serotonin-containing dorsal raphe neurons possess autoreceptors? Exp. Brain Res. 62:579-586; 1986.
68. Trulson, M. E.; Howell, G. A.; Brandsetter, J. W.; Frederickson, M. H.; Federickson, C. J. In vitro recording of raphe unit activity: Evidence for endogenous rhythms in presumed serotonergic neurons. Life Sci. 31:785-790; 1982.
69. Trulson, M. E.; Frederickson, C. R. A comparison of the electrophysiological and pharmacological properties of serotonin-containing neurons in the nucleus raphe dorsalis, raphe medianus and raphe pallidus recorded from mouse brain slices in vitro: Role of autoreceptors. Brain Res Bull. 18:179-190; 1987.
70. Vandermaelen, C. P.; Aghajanian, G. K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 289:109-119; 1983.
71. Vizi, E. S. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Brain Res. Bull. 52:63-88; 2000.
72. Vizi, E. S.; Kiss, J. P. Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and nonsynaptic interactions. Hippocampus 8:566-607; 1998.